ARQ vs PURE: stock comparison and AI forecast
Arq, Inc. (ARQ) and Pure Bioscience, Inc. (PURE) compared on price performance, valuation, profitability and the daily AI forecast. · Alpha · vs market
Share
ARQ Arq, Inc.
- Market Cap
- $105M
- P/E Ratio
- –
- Size
- small-cap
- AI Forecast
PURE Pure Bioscience, Inc.
- Market Cap
- $9M
- P/E Ratio
- –
- Size
- small-cap
- AI Forecast
Which one does the AI model favor?
Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.
Key facts
- ARQ is 12.1 times larger than PURE by market capitalization ($105M against $9M).
- ARQ turns -38.8% of its revenue into net income, against -107.3% for PURE.
- Both companies share the SEC industry classification Miscellaneous Chemical Products.
Fundamentals side by side
Trailing twelve months.
Valuation & Market
| Metric | ARQ | PURE |
|---|---|---|
| Market Cap | $105M | $9M |
| P/B Ratio | 0.61x | – |
| EPS | $-1.19 | $-0.02 |
| Book Value/Share | $3.94 | – |
| Revenue/Share | $2.90 | $0.02 |
| FCF/Share | $0.03 | – |
Profitability & Margins
| Metric | ARQ | PURE |
|---|---|---|
| ROE | -28.6% | – |
| ROA | -21.0% | -208.1% |
| ROIC | -25.9% | 65.5% |
| Gross Margin | 32.1% | 57.3% |
| Operating Margin | -39.1% | -90.0% |
| Net Margin | -38.8% | -107.3% |
| EBT Margin | -39.0% | -90.0% |
| Tax Rate | -0.0% | 0.0% |
Financial Health
| Metric | ARQ | PURE |
|---|---|---|
| Current Ratio | 1.20x | 0.27x |
| Quick Ratio | 0.79x | 0.23x |
| D/E Ratio | 0.36x | – |
| Financial Leverage | 1.36x | – |
| Interest Coverage | -77.5x | -4.8x |
| Working Capital | $8M | -$3M |
Cash Flow
| Metric | ARQ | PURE |
|---|---|---|
| Operating Cash Flow | $5M | -$2M |
| Free Cash Flow | $1M | – |
| Capital Spending | -$4M | – |
| OCF Growth YoY | -5.9% | – |
| FCF/Sales | 1.1% | – |
| CapEx/Sales | 2.8% | – |
Operational Efficiency
| Metric | ARQ | PURE |
|---|---|---|
| Asset Turnover | 0.54x | 1.94x |
| Receivables Turnover | 6.3x | 6.9x |
| Inventory Turnover | 5.0x | 5.1x |
| Fixed Assets Turnover | 0.9x | 289.4x |
| Days Sales Outstanding | 58 days | 53 days |
| Days Inventory | 73 days | 71 days |
| Payables Period | 63 days | 302 days |
| Cash Conversion Cycle | 68 days | -178 days |
Income Statement
| Metric | ARQ | PURE |
|---|---|---|
| Total Revenue | $127M | $2M |
| Operating Income | -$49M | -$2M |
| Net Income | -$49M | -$2M |
| R&D Expense | $4M | $330K |
| SG&A Expense | $27M | $3M |
| Cost of Goods Sold | $86M | $990K |
Dividend & Shareholder Information
| Metric | ARQ | PURE |
|---|---|---|
| Shares Outstanding | 44M | 140M |
ARQ vs PURE: stock comparison and AI forecast
Which is bigger, ARQ or PURE?
ARQ is 12.1 times larger than PURE by market capitalization ($105M against $9M).
Which one does Intratio's AI model rank higher, ARQ or PURE?
Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.
This analysis is generated automatically using our proprietary AI systems and should not be considered personalized investment advice. Past performance does not guarantee future results. Always conduct your own research and consider consulting a financial advisor before making investment decisions.